 1993; 52: 672-676) 
way has been shown to affect lymphocyte recirculation and homing in a non-organ specific way,'2 13 whereas the VLA-4NCAM-I pathway plays an important part in lymphocyte migration into inflamed tissues.14 It has been recognised that VLA-4 not only functions as a cell receptor for VCAM-I9'1 but also as an extracellular matrix receptor for an alternatively spliced domain of fibronectin (CSI). '6-18 As in rats CS1 has been found to support the adhesion of lymphocytes to cultured peripheral lymph node (PLN)-high endothelial cells, '9 we wanted to establish whether CS1 also mediates lymphocyte-HEV interactions in humans. Expression of functional HEV binding ability was tested in a modified in vitro frozen section assay in which lymphocytes bind to HEVs of PLNs or inflamed synovial membranes. The results show that the CS1 adhesive motif of fibronectin affects physiological lymphocyte recirculation via PLN as well as lymphocyte migration to inflamed synovial tissue.
Materials and methods

PEPTIDES
The CS 1 peptide was used to investigate involvement of the type III connecting segment (IIICS) cell binding domain of fibronectin in lymphocyte adhesion. The adjacent peptide sequence (CS2) was used as a control. Peptides were synthesised and purified as described by Humphries et al. 8 As the maximum inhibition of T lymphocyte-HEV binding was obtained using concentrations exceeding 0 10 mg peptide/ml, a concentration of 0 15 mg/ml was used throughout the study.
MONOCLONAL ANTIBODIES
The monoclonal antibodies used were CLB-45 (IgGl) specific for CD452"; HP2/1 (IgGl) and SANI (IgGl) specific for the cx chain of VLA- As fibronectin was also expressed on PLN HEVs we examined whether the CS 1 peptide had the same inhibitory effect on T lymphocyte REV interaction in PLNs. In the presence of the control peptide CS2 or the non-blocking monoclonal antibody against CD45, the level of T cell adhesion ranged from 13-9 to 14-7/ mm REV (100%). The CSI peptide reduced the total number of adherent T cells by 45 (9)% (p<0OOO5) (fig 3) . Also, the antibody to fibronectin inhibited T lymphocyte binding by 47 
Discussion
Previously we have shown that the VLA-4NCAM-1 pathway mediates peripheral blood lymphocyte adhesion to inflamed rheumatoid synovium whereas L-selectin (LECAM-1) and CD44 are of major importance in the adhesion of peripheral blood lymphocytes to PLN HEVs. 14 Using a novel in vitro model of binding of lymphocytes to HEVs in rats, Ager and Humphries showed that lymphocyte adhesion to the surface of cultured PLN-HEV cells can also be inhibited by the CS1 motif in the IIICS of fibronectin."9 On this basis they suggested that the ligand on HEVs that could be inhibited by CS 1 might be a cell surface form of fibronectin. The aim of this study was to determine whether the CS 1 peptide also affects the binding of peripheral blood lymphocytes to HEVs in PLNs and endothelium in inflamed rheumatoid synovium in humans.
Fibronectin staining of endothelium was often most intense at the basal lamina and at the endothelial surface in inflamed synovium and PLNs as described previously. Szekanecz et al27 in a rat model. In the first study, CS1 peptide inhibited lymphocyte adhesion to the surface of cultured rat HEV cells, but had no effect on lymphocyte migration. In the latter study it was found that VLA-5 not only played a part in lymphocyte adhesion to cultured PLN-HEV, but also in lymphocyte transmigration. In 
